FY24 consensus $10.67. Backs FY24 operational sales growth view of 5.0%-6.0%, consensus $87.97B
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on JNJ:
- GLP-1 Anti-Obesity Drugs: Slim Waistlines, Fat Profits
- Options Volatility and Implied Earnings Moves This Week, January 22 – January 26, 2024
- JNJ Earnings this Week: How Will it Perform?
- Senate Health, Education, Labor & Pensions Committee holds an executive session
- J&J says FDA grants full approval for Balversa for mUC with genetic alterations